FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 348:1356-1364 April 3, 2003 Number 14 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article PubMed Citation

The incidence of many common diseases is increased among the relatives of affected patients, but the pattern of inheritance rarely follows Mendel's laws. Instead, such common diseases are thought to result from a complex interaction among multiple predisposing genes and other factors, including environmental contributions and chance occurrences. Identifying the genetic contribution to such complex diseases is a major challenge for genomic medicine. However, as so clearly foreseen nearly 350 years ago by the English physiologist William Harvey,¹ finding the genetic basis for rarer, mendelian forms of a disease may illuminate the etiologic process and pathogenesis of the more common, . . . [Full Text of this Article]

Alzheimer's Disease

Parkinson's Disease

Conclusions

Source Information

From the Genetic Diseases Research Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Md.

Address reprint requests to Dr. Nussbaum at the Genetic Diseases Research Branch, National Human Genome Research Institute, NIH, 49 Convent Dr., Rm. 4A72, Bethesda, MD 20892-4472, or at rlnuss@nhgri.nih.gov.

Related Letters:

Genetics of Neurodegenerative Disorders
Caruso C., Franceschi C., Licastro F., Nussbaum R., Ellis C.
Extract | Full Text | PDF  
N Engl J Med 2003; 349:193-194, Jul 10, 2003. Correspondence

This article has been cited by other articles:

• Berger, A. K., Cortese, G. P., Amodeo, K. D., Weihofen, A., Letai, A., LaVoie, M. J. (2009). Parkin selectively alters the intrinsic threshold for mitochondrial cytochrome c release. Hum Mol Genet 18: 4317-4328 [Abstract] [Full Text]  
• Kum, W. F., Durairajan, S. S. K., Bian, Z. X., Man, S. C., Lam, Y. C., Xie, L. X., Lu, J. H., Wang, Y., Huang, X. Z., Li, M. (2009). Treatment of Idiopathic Parkinson's Disease with Traditional Chinese Herbal Medicine: A Randomized Placebo-Controlled Pilot Clinical Study. Evid Based Complement Alternat Med 0: nep116v1-nep116 [Abstract] [Full Text]  
• Archibald, N. K., Clarke, M. P., Mosimann, U. P., Burn, D. J. (2009). The retina in Parkinson's disease. Brain 132: 1128-1145 [Abstract] [Full Text]  
• Drobysheva, D., Ameel, K., Welch, B., Ellison, E., Chaichana, K., Hoang, B., Sharma, S., Neckameyer, W., Srinakevitch, I., Murphy, K. J., Schmid, A. (2008). An Optimized Method for Histological Detection of Dopaminergic Neurons in Drosophila melanogaster. J. Histochem. Cytochem. 56: 1049-1063 [Abstract] [Full Text]  
• Schaffer, B. A. J., Bertram, L., Miller, B. L., Mullin, K., Weintraub, S., Johnson, N., Bigio, E. H., Mesulam, M., Wiedau-Pazos, M., Jackson, G. R., Cummings, J. L., Cantor, R. M., Levey, A. I., Tanzi, R. E., Geschwind, D. H. (2008). Association of GSK3B With Alzheimer Disease and Frontotemporal Dementia. Arch Neurol 65: 1368-1374 [Abstract] [Full Text]  
• Hamshere, M. L., Holmans, P. A., Avramopoulos, D., Bassett, S. S., Blacker, D., Bertram, L., Wiener, H., Rochberg, N., Tanzi, R. E., Myers, A., Wavrant-De Vrieze, F., Go, R., Fallin, D., Lovestone, S., Hardy, J., Goate, A., O'Donovan, M., Williams, J., Owen, M. J. (2007). Genome-wide linkage analysis of 723 affected relative pairs with late-onset Alzheimer's disease. Hum Mol Genet 16: 2703-2712 [Abstract] [Full Text]  
• Liu, C., Fei, E., Jia, N., Wang, H., Tao, R., Iwata, A., Nukina, N., Zhou, J., Wang, G. (2007). Assembly of Lysine 63-linked Ubiquitin Conjugates by Phosphorylated {alpha}-Synuclein Implies Lewy Body Biogenesis. J. Biol. Chem. 282: 14558-14566 [Abstract] [Full Text]  
• Boddaert, J., Kinugawa, K., Lambert, J.-C., Boukhtouche, F., Zoll, J., Merval, R., Blanc-Brude, O., Mann, D., Berr, C., Vilar, J., Garabedian, B., Journiac, N., Charue, D., Silvestre, J.-S., Duyckaerts, C., Amouyel, P., Mariani, J., Tedgui, A., Mallat, Z. (2007). Evidence of a Role for Lactadherin in Alzheimer's Disease. Am. J. Pathol. 170: 921-929 [Abstract] [Full Text]  
• Klafki, H.-W., Staufenbiel, M., Kornhuber, J., Wiltfang, J. (2006). Therapeutic approaches to Alzheimer's disease. Brain 129: 2840-2855 [Abstract] [Full Text]  
• de Lau, L. M. L., Koudstaal, P. J., Hofman, A., Breteler, M. M. B. (2006). Subjective Complaints Precede Parkinson Disease: The Rotterdam Study. Arch Neurol 63: 362-365 [Abstract] [Full Text]  
• Huang, X., Chen, P., Kaufer, D. I., Troster, A. I., Poole, C. (2006). Apolipoprotein E and Dementia in Parkinson Disease: A Meta-analysis. Arch Neurol 63: 189-193 [Abstract] [Full Text]  
• Ulmer, T. S., Bax, A. (2005). Comparison of Structure and Dynamics of Micelle-bound Human {alpha}-Synuclein and Parkinson Disease Variants. J. Biol. Chem. 280: 43179-43187 [Abstract] [Full Text]  
• Mor, F., Izak, M., Cohen, I. R. (2005). Identification of Aldolase as a Target Antigen in Alzheimer's Disease. J. Immunol. 175: 3439-3445 [Abstract] [Full Text]  
• Bernardini, S., Bellincampi, L., Ballerini, S., Federici, G., Iori, R., Trequattrini, A., Ciappi, F., Baldinetti, F., Bossu, P., Caltagirone, C., Spalletta, G. (2005). Glutathione S-Transferase P1 *C Allelic Variant Increases Susceptibility for Late-Onset Alzheimer Disease: Association Study and Relationship with Apolipoprotein E {epsilon}4 Allele. Clin. Chem. 51: 944-951 [Abstract] [Full Text]  
• Ulmer, T. S., Bax, A., Cole, N. B., Nussbaum, R. L. (2005). Structure and Dynamics of Micelle-bound Human {alpha}-Synuclein. J. Biol. Chem. 280: 9595-9603 [Abstract] [Full Text]  
• Bird, T. D. (2005). Genetic Factors in Alzheimer's Disease. NEJM 352: 862-864 [Full Text]  
• Feany, M. B. (2004). New Genetic Insights into Parkinson's Disease. NEJM 351: 1937-1940 [Full Text]  
• Aharon-Peretz, J., Rosenbaum, H., Gershoni-Baruch, R. (2004). Mutations in the Glucocerebrosidase Gene and Parkinson's Disease in Ashkenazi Jews. NEJM 351: 1972-1977 [Abstract] [Full Text]  
• Gorelick, P. B. (2004). Risk Factors for Vascular Dementia and Alzheimer Disease. Stroke 35: 2620-2622 [Abstract] [Full Text]  
• de Lau, L. M.L., Giesbergen, P. C.L.M., de Rijk, M. C., Hofman, A., Koudstaal, P. J., Breteler, M. M.B. (2004). Incidence of parkinsonism and Parkinson disease in a general population: The Rotterdam Study. Neurology 63: 1240-1244 [Abstract] [Full Text]  
• Levy, G., Louis, E. D., Mejia-Santana, H., Cote, L., Andrews, H., Harris, J., Waters, C., Ford, B., Frucht, S., Fahn, S., Ottman, R., Marder, K. (2004). Lack of Familial Aggregation of Parkinson Disease and Alzheimer Disease. Arch Neurol 61: 1033-1039 [Abstract] [Full Text]  
• Zhou, D., Noviello, C., D'Ambrosio, C., Scaloni, A., D'Adamio, L. (2004). Growth Factor Receptor-bound Protein 2 Interaction with the Tyrosine-phosphorylated Tail of Amyloid {beta} Precursor Protein Is Mediated by Its Src Homology 2 Domain. J. Biol. Chem. 279: 25374-25380 [Abstract] [Full Text]  
• Qiu, C, Kivipelto, M, Aguero-Torres, H, Winblad, B, Fratiglioni, L (2004). Risk and protective effects of the APOE gene towards Alzheimer's disease in the Kungsholmen project: variation by age and sex. J. Neurol. Neurosurg. Psychiatry 75: 828-833 [Abstract] [Full Text]  
• Ajilore, O. A., Kumar, A. (2004). Delirium and Dementia. Focus 2: 210-220 [Abstract] [Full Text]  
• RECCHIA, A., DEBETTO, P., NEGRO, A., GUIDOLIN, D., SKAPER, S. D., GIUSTI, P. (2004). {alpha}-Synuclein and Parkinson's disease. FASEB J. 18: 617-626 [Abstract] [Full Text]  
• Choi, J., Levey, A. I., Weintraub, S. T., Rees, H. D., Gearing, M., Chin, L.-S., Li, L. (2004). Oxidative Modifications and Down-regulation of Ubiquitin Carboxyl-terminal Hydrolase L1 Associated with Idiopathic Parkinson's and Alzheimer's Diseases. J. Biol. Chem. 279: 13256-13264 [Abstract] [Full Text]  
• Lidman, O., Swanberg, M., Horvath, L., Broman, K. W., Olsson, T., Piehl, F. (2003). Discrete Gene Loci Regulate Neurodegeneration, Lymphocyte Infiltration, and Major Histocompatibility Complex Class II Expression in the CNS. J. Neurosci. 23: 9817-9823 [Abstract] [Full Text]  
• Merikangas, K. R., Risch, N. (2003). Genomic Priorities and Public Health. Science 302: 599-601 [Abstract] [Full Text]  
• Scheinfeld, M. H., Ghersi, E., Davies, P., D'Adamio, L. (2003). Amyloid {beta} Protein Precursor Is Phosphorylated by JNK-1 Independent of, yet Facilitated by, JNK-Interacting Protein (JIP)-1. J. Biol. Chem. 278: 42058-42063 [Abstract] [Full Text]  
• Dong, Z., Ferger, B., Paterna, J.-C., Vogel, D., Furler, S., Osinde, M., Feldon, J., Bueler, H. (2003). Dopamine-dependent neurodegeneration in rats induced by viral vector-mediated overexpression of the parkin target protein, CDCrel-1. Proc. Natl. Acad. Sci. USA 100: 12438-12443 [Abstract] [Full Text]  
• Van Deerlin, V. M., Gill, L. H., Farmer, J. M., Trojanowski, J. Q., Lee, V. M-Y. (2003). Familial Frontotemporal Dementia: From Gene Discovery to Clinical Molecular Diagnostics. Clin. Chem. 49: 1717-1725 [Abstract] [Full Text]  
• Guttmacher, A. E., Collins, F. S. (2003). Welcome to the Genomic Era. NEJM 349: 996-998 [Full Text]  
• (2003). Implications of Genetic Advances in Alzheimer's and Parkinson Disease. JWatch Psychiatry 2003: 9-9 [Full Text]  
• Martyn, C. (2003). Anti-inflammatory drugs and Alzheimer's disease. BMJ 327: 353-354 [Full Text]  
• Merlini, G., Bellotti, V. (2003). Molecular Mechanisms of Amyloidosis. NEJM 349: 583-596 [Full Text]  
• (2003). Implications of Genetic Advances in Alzheimer's and Parkinson Disease. JWatch Neurology 2003: 5-5 [Full Text]  
• Caruso, C., Franceschi, C., Licastro, F., Nussbaum, R., Ellis, C. (2003). Genetics of Neurodegenerative Disorders. NEJM 349: 193-194 [Full Text]